Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1822-2025

ADVIA Centaur HCY Calibrator (2 Pack). Siemens Material Number: 10310376. Recall

ADVIA Centaur HCY Calibrator (2 Pack). Siemens Material Number: 10310376.

FDA recall Class II

Ongoing

FDA lists this Class II recall for ADVIA Centaur HCY Calibrator (2 Pack). Siemens Material Number: 10310376.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1822-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 15, 2025
FDA report date
Jun 4, 2025
Quantity in commerce
1,072 packs (2,144 units) - 156 packs US, 916 packs OUS
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

ADVIA Centaur HCY Calibrator (2 Pack). Siemens Material Number: 10310376.

Affected model & UDI checker

Search the exact identifiers published for Z-1822-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedADVIA Centaur HCY Calibrator (2 Pack). Siemens Material Number: 10310376.Check source notice00630414468198
FDA code information

Siemens Material Number: 10310376. UDI-DI 00630414468198 Kit lot numbers: 86237A74, 44207A75. ***Updated 5/8/26*** Additional lots 25674A77 52363A79

View the original FDA recall notice

Why was this product recalled?

Certain lots of Atellica IM Homocysteine Calibrator and ADVIA Centaur HCY Calibrator do not meet the assay Instructions for Use (IFU) reference interval due to calibrator instability resulting in increased positive bias.

What actions did Siemens Healthcare Diagnostics, Inc. take?

An Urgent Medical Device Correction (UMDC) was mailed to all US affected customers by FedEx, and an Urgent Field Safety Notice (UFSN) was issued to all OUS Siemens reporting sites with affected customers on about 04/15/2025. Customers were instructed to review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, discontinue use of and discard the affected devices, and complete and return the Effectiveness Check questionnaire. Customers were also instructed to forward the letter to those who may have received the affected devices. ***Updates: ***On 10/21/25, a second notice was mailed to all affected US customers to inform them that an additional lot was added to the scope of the recall. Kit lots ending in 77 are affected. ***On 5/1/26, a third notice was mailed to all affected US customers to inform them that an additional affected lot was added. Kit lots ending in 78 and 79 are affected.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology